One of the few treatments for DMD patients are corticosteroids (prednisone/prednisolone/deflazacort) acting to exert immunosuppressive and anti-inflammatory effects, reduce fibrosis, muscle cell proteolysis, upregulate utrophin, and improve muscle strength and functional outcome [44–47]. This evidence concerns the gene UTRN and Duchenne muscular dystrophy.